New Russian antiretroviral expected to launch in next 3-4 years

A new drug for antiretroviral therapy is undergoing clinical trials at the Central Research Institute of Epidemiology of the Russian Federal Service on Surveillance for Consumer rights protection and human well-being (Rospotrebnadzor).

The new drug is scheduled for market launch already in 2020-2021, and will be an alternative for the strict regimen constant side effects associated with HIV treatment, reports The Pharma Letter’s local correspondent.

According to Dmitry Kireev, head of the group for developing new methods for diagnosing HIV infection and viral hepatitis of the Institute, the drug is made on the basis of nanosuspensions, which are slowly consumed in the body, being present in all tissues of the patient’s body at the right levels.